BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30829137)

  • 1. Vitamin D supplementation has no effect on matrix metalloproteinases-2, -9, and tissue inhibitor matrix metalloproteinase-1 in subjects with metabolic syndrome: A pilot study.
    Ghezel A; Salekzamani S; Mehralizadeh H; Jafarabadi MA; Gargari BP
    Int J Vitam Nutr Res; 2019 Nov; 89(5-6):227-237. PubMed ID: 30829137
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.
    Salekzamani S; Bavil AS; Mehralizadeh H; Jafarabadi MA; Ghezel A; Gargari BP
    Endocrine; 2017 Jul; 57(1):51-59. PubMed ID: 28509078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.
    Salekzamani S; Mehralizadeh H; Ghezel A; Salekzamani Y; Jafarabadi MA; Bavil AS; Gargari BP
    J Endocrinol Invest; 2016 Nov; 39(11):1303-1313. PubMed ID: 27400997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of conjugated linoleic acid supplementation on inflammatory factors and matrix metalloproteinase enzymes in rectal cancer patients undergoing chemoradiotherapy.
    Mohammadzadeh M; Faramarzi E; Mahdavi R; Nasirimotlagh B; Asghari Jafarabadi M
    Integr Cancer Ther; 2013 Nov; 12(6):496-502. PubMed ID: 23632235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and alpha2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids.
    Vogt J; Andersen VL; Andreasen A; Obel T; Christensen JH; Schmidt EB
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):102-9. PubMed ID: 20196974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance training modifies of serum levels of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases in multiple sclerosis women - a randomized controlled trail.
    Nezhad NN; Parnow A; Khamoushian K; Eslami R; Baker JS
    BMC Neurosci; 2024 Mar; 25(1):13. PubMed ID: 38438999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
    Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
    Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
    Huang Y; Shen L; Cai A; Xiao J
    J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome.
    Tsilingaridis G; Yucel-Lindberg T; Modéer T
    J Periodontal Res; 2013 Oct; 48(5):553-62. PubMed ID: 23298307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
    Zhang ZL; Lin JH; Tao RQ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients.
    Farsad-Naeimi A; Alizadeh M; Esfahani A; Darvish Aminabad E
    Food Funct; 2018 Apr; 9(4):2025-2031. PubMed ID: 29541713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis.
    Choi DH; Moon IS; Choi BK; Paik JW; Kim YS; Choi SH; Kim CK
    J Periodontal Res; 2004 Feb; 39(1):20-6. PubMed ID: 14687223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
    Raygan F; Ostadmohammadi V; Bahmani F; Asemi Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):50-55. PubMed ID: 29432877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
    Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.